Prostate Cancer Foundation of Australia

Last updated

Prostate Cancer Foundation of Australia
Type Non-Profit
Founded1996 in Lane Cove NSW
FounderRotary Club of Lane Cove
HeadquartersL3 39-41 Chandos Street
St Leonards NSW 2065
Australia
Key people
Steve Callister (National Chairman)
Chris Hall (National Deputy Chairman)
Professor Jeff Dunn AO (CEO)
Website pcfa.org.au

Prostate Cancer Foundation of Australia is a broad-based community organisation and the peak national body for prostate cancer in Australia. The Foundation is dedicated to reducing the impact of prostate cancer on Australian men, their partners and families, recognising the diversity of the Australian community. Prostate Cancer Foundation of Australia receives Government funding for specific projects and relies on the generosity of individuals, the community and partnerships to carry out its work. [1]

Contents

History

Prostate Cancer Foundation of Australia was formed in Sydney in 1996. The television personality, Roger Climpson OAM, a member of the Rotary Club of Lane Cove, was treated successfully for prostate cancer in 1994. Roger was concerned by the confusing information available to him at the time of diagnosis and treatment and by the apparent lack of research into the disease being carried out in Australia. In 1996 he persuaded fellow club members to join him in forming the Prostate Cancer Research Foundation (PCRF) to raise funds for research.[ citation needed ]

Then in 1998 a committee of support group representatives from the greater Sydney and Newcastle area formed the Association of Prostate Cancer Support Groups (APCSG) that had a state focus but hoped to connect support groups nationally.[ citation needed ]

APCSG led by Max Gardner AM moved to affiliate with PCRF. As this occurred another NSW based fundraising group, the Australian Prostate Cancer Foundation (APCF) also emerged. In 1999 PCRF, APCF and APSCG merged under PCRF's corporate structure and the new name Prostate Cancer Foundation of Australia was chosen to reflect the organisation's widened agenda. Within this the APSCG maintained its own identity and autonomy.[ citation needed ]

It was not until 2001 that the relationship between the national support group movement and PCFA was clearly and formally established. At this point there were 40 support groups across the country. The key pivotal moment was an Inaugural Conference of Affiliated Prostate Cancer Support Groups (organised by PCFA) that provided the first national forum for support group representatives across Australia to connect and devise strategies to address priority issues for prostate cancer survivors and advance the broader movement. At this conference the support groups declared PCFA as the peak national body for prostate cancer and the Association of Prostate Cancer Support Groups became the Support and Advocacy Committee (now known as the National Support Groups Committee) within PCFA's governance structure.[ citation needed ]

Work

Prostate Cancer Foundation of Australia works across three broad areas[ citation needed ]

Research

Prostate Cancer Foundation of Australia provides funding for prostate cancer research in Australia. The Foundation has a responsibility to the generous public who funds prostate cancer research; it must invest its research funds wisely. By consulting widely with Australian men with prostate cancer and those who care for them, the Foundation directs funds to research projects that best address their needs.[ citation needed ]

Prostate Cancer Foundation of Australia's research strategy [2] provides a clear, long term, approach to funding. Its overarching goal is to create and promote the uptake of knowledge that will improve the lives of Australian men with prostate cancer, their partners and their families.[ citation needed ]

The objectives of Prostate Cancer Foundation of Australia's research program are:

Awareness

Prostate cancer remains a significant killer of men in Australia [3] yet understanding about the disease is lacking in many sectors of the broader population. [4] A primary focus of Prostate Cancer Foundation of Australia's awareness activities is to inform the entire community about this important health issue.[ citation needed ]

Ambassador Program

The Ambassador Program is a community education program aiming to raise awareness of prostate cancer and provide resources from which participants can further their knowledge. [5] Approximately one hundred ambassadors are currently trained to deliver presentations to the public about prevention and early detection, treatment options and challenges. The Ambassador Program operates in all States and Territories of Australia.

Evidence-based resources

Research conducted by Prostate Cancer Foundation of Australia in partnership with La Trobe University [6] [7] identified a need to target prostate cancer information toward different audience groups. As part of the Supporting men with prostate cancer through evidence-based resources and support project, a Cancer Australia initiative funded by the Australian Government, Prostate Cancer Foundation of Australia has produced a series of information booklets to cater to men with localised prostate cancer, men with advanced prostate cancer, partners and carers, gay and bisexual men, and younger men. Each series contains four booklets covering diagnosis, treatment, side effects and wellbeing. Each booklet can be read as a standalone resource or as part of the set. The resources are available through Prostate Cancer Foundation of Australia's support group network, hospitals, from Prostate Cancer Specialist Nurses, cancer centres and GPs. Prostate Cancer Foundation of Australia also provides translated key resources into five languages – Arabic, Chinese, Greek, Italian and Vietnamese and a flip chart for Aboriginal and Torres Strait Islander men.[ citation needed ]

National clinical guidelines

In partnership with Cancer Council Australia and a multi-disciplinary expert advisory panel comprising urologists, radiation oncologists, pathologists, general practitioners, medical oncologists, epidemiologists, allied health professionals and consumers, Prostate Cancer Foundation of Australia has developed national evidence-based clinical practice guidelines on PSA testing and early management of test-detected prostate cancer.[ citation needed ]

The guideline recommendations have been approved by the CEO of the National Health and Medical Research Council, Australia's leading expert body for developing health advice for the Australian community, health professionals and governments.[ citation needed ]

Prostate Cancer Foundation of Australia developed the guidelines in order to resolve the controversy surrounding PSA testing for both men and their doctors. The guidelines do not recommend a population screening program for prostate cancer (a program that offers testing to all men of a certain age group) as evidence does not support such a program. For men who decide to be tested it contains guidance on matters such as what age to start testing; how frequently to be tested; when to stop testing; the PSA level which should prompt further investigation; family history; and the role of the digital rectal examination.[ citation needed ]

Support

A central part of Prostate Cancer Foundation of Australia's activities is to support men and their families affected by prostate cancer through the development and delivery of evidence-based information and through its network of Support Groups and Prostate Cancer Specialist Nurses.

Support groups

Prostate Cancer Foundation of Australia's network of support groups has grown rapidly in recent years and now comprises over 150 affiliated groups across Australia, [8] sharing information, providing encouragement and raising awareness amongst men diagnosed with prostate cancer and their families. Support groups provide reassurance to men with prostate cancer from others who have personal experience of the challenges they are facing. Men who attend support groups are able to talk through the pros and cons of treatment options with other men, compare their physical and mental wellbeing and outcomes, and benchmark their own progress along the cancer journey.[ citation needed ]

Prostate Cancer Specialist Nursing Service

The Prostate Cancer Specialist Nursing Service supports the placement of prostate cancer specialist nurses in a variety of Australian health care settings in partnership with health service providers.

The Prostate Cancer Specialist Nursing Service has been made possible thanks to funding from the Federal Government and generous local and community supporters.

Prostate Cancer Specialist Nurses work within an agreed Practice Framework and Competency Standards which are based on nationally recognised best practice models. Prostate Cancer Foundation of Australia is committed to providing ongoing professional development and support for the duration of the program.

Prostate Cancer Specialist Nurses work as part of a multidisciplinary team to provide a point of contact for men and offer continuity of care from diagnosis onwards. They see patients at any point during their cancer journey and help patients and their families to navigate the complex system of health services, make decisions about treatment options, and manage side effects of treatment.

Related Research Articles

<span class="mw-page-title-main">Prostate cancer</span> Male reproductive organ cancer

Cancer of the prostate is the second most common cancerous tumor worldwide and is the fifth leading cause of cancer-related mortality among men. The prostate is a gland in the male reproductive system that surrounds the urethra just below the bladder. Most prostate cancers are slow growing. Cancerous cells may spread to other areas of the body, particularly the bones and lymph nodes. It may initially cause no symptoms. In later stages, symptoms include pain or difficulty urinating, blood in the urine, or pain in the pelvis or back. Benign prostatic hyperplasia may produce similar symptoms. Other late symptoms include fatigue, due to low levels of red blood cells.

<span class="mw-page-title-main">Prostate-specific antigen</span> Mammalian protein found in humans

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland.

<span class="mw-page-title-main">Palestine Children's Relief Fund</span>

The Palestine Children's Relief Fund (PCRF) is a registered 501(c)(3) non-governmental organization established in 1991, by, according to its website, "concerned people in the U.S. to address the medical and humanitarian crisis facing Palestinian youths in the Middle East." The main objective of the PCRF is to locate in the United States and Europe free medical care for children who cannot be adequately treated in the Middle East. Since 1991, tens of thousands of young people have received medical treatment through the PCRF.

<span class="mw-page-title-main">Nurse practitioner</span> Mid-level medical provider

A nurse practitioner (NP) is an advanced practice registered nurse and a type of mid-level practitioner. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans. NP training covers basic disease prevention, coordination of care, and health promotion, but does not provide the depth of expertise needed to recognize more complex conditions.

<span class="mw-page-title-main">Movember</span> Annual event to raise awareness of mens health problems

Movember is an annual event involving the growing of moustaches during the month of November to raise awareness of men's health issues, such as prostate cancer, testicular cancer, and men's suicide. It is a portmanteau of the Australian-English diminutive word for moustache, "mo", and "November". The Movember Foundation runs the Movember charity event, housed at Movember.com. The goal of Movember is to "change the face of men's health."

<span class="mw-page-title-main">Screening (medicine)</span> Brief medical evaluation to detect unnoticed health problems

Screening, in medicine, is a strategy used to look for as-yet-unrecognised conditions or risk markers. This testing can be applied to individuals or to a whole population. The people tested may not exhibit any signs or symptoms of a disease, or they might exhibit only one or two symptoms, which by themselves do not indicate a definitive diagnosis.

Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in men without signs or symptoms. When abnormal prostate tissue or cancer is found early, it may be easier to treat and cure, but it is unclear if early detection reduces mortality rates.

International Men's Health Week (IMHW) is an international week celebrated in several countries the week preceding and including Father's Day to focus on issues facing men's health. International Men's Health Week began at an international level in 2002 when representatives from six men's health organizations around the world met in a meeting organized by Men's Health Network at the 2nd World Congress on Men's Health in Vienna, Austria, and resolved to work together to launch IMHW. This meeting followed preliminary discussions in 2001, at the first World Congress on Men's Health, about the need to coordinate awareness periods around the globe.

Patient advocacy is a process in health care concerned with advocacy for patients, survivors, and caregivers. The patient advocate may be an individual or an organization, concerned with healthcare standards or with one specific group of disorders. The terms patient advocate and patient advocacy can refer both to individual advocates providing services that organizations also provide, and to organizations whose functions extend to individual patients. Some patient advocates are independent and some work for the organizations that are directly responsible for the patient's care.

<span class="mw-page-title-main">McGrath Foundation</span>

The McGrath Foundation is a breast cancer support and education charity in Australia, which raises money to place McGrath Breast Care Nurses in communities across Australia and increase breast health awareness. The charity was founded by Australian cricket player Glenn McGrath and his English-born wife, Jane McGrath, in 2005, following Jane's initial diagnosis and recovery from breast cancer. Jane died on 22 June 2008 at the age of 42.

<span class="mw-page-title-main">Prostate Cancer Foundation</span> American non-profit organization

The Prostate Cancer Foundation (PCF), headquartered in Santa Monica, California, funds research into the prevention and cure of prostate cancer.

<span class="mw-page-title-main">Cancer screening</span> Method to detect cancer

Cancer screening aims to detect cancer before symptoms appear. This may involve blood tests, urine tests, DNA tests, other tests, or medical imaging. The benefits of screening in terms of cancer prevention, early detection and subsequent treatment must be weighed against any harms.

<span class="mw-page-title-main">ZERO—The End of Prostate Cancer</span> U.S. nonprofit organization

ZERO - The End of Prostate Cancer is a 501(c)(3) non-profit organization dedicated to prostate cancer education, testing, patient support, research and advocacy.

<span class="mw-page-title-main">International Myeloma Foundation</span> American non-profit organization

The International Myeloma Foundation (IMF) is an American non-profit organization serving patients with myeloma, a cancer of plasma cells in the bone marrow. The IMF also provides support and information for family members, caregivers of myeloma patients, physicians and nurses. The organization is dedicated to improving the quality of life for all myeloma patients by focusing on four key areas: research, education, support, and advocacy.

<span class="mw-page-title-main">Active surveillance of prostate cancer</span>

Active surveillance is a management option for localized prostate cancer that can be offered to appropriate patients who would also be candidates for aggressive local therapies, with the intent to intervene if the disease progresses. Active surveillance should not be confused with watchful waiting, another observational strategy for men that would not be candidates for curative therapy because of a limited life expectancy. Active surveillance offers men with a prostate cancer that is thought to have a low risk of causing harm in the absence of treatment, a chance to delay or avoid aggressive treatment and its associated side effects.While prostate cancer is the most common non cutaneous cancer and second leading cause of cancer-related death in American men, it is conservatively estimated that approximately 100,000 men per year in the United States who would be eligible for conservative treatment through active surveillance, undergo unnecessary treatments. The management of localized prostate cancer is controversial and men with localized disease diagnosed today often undergo treatments with significant side effects that will not improve overall health outcomes. The 2011 NIH State-of-the-Science Conference Statement on the "Role of active surveillance in the management of men with localized prostate cancer" pointed out the many unanswered questions about observational strategies for prostate cancer that require further research and clarification. These included:

<span class="mw-page-title-main">Anthony Lowe</span> Australian scientist (born 1962)

Anthony Peter Lowe AP is a British-Australian mathematical physicist and actuary. He previously served as chief executive officer of the Prostate Cancer Foundation of Australia, and is a frequent media commentator on prostate cancer and prostate specific antigen (PSA) testing.

The Distinguished Gentleman's Ride is a global motorcycle event raising funds and awareness for prostate cancer research and men's mental health programs on behalf of the Movember Foundation.

Founded in 1965, the foundation's key role is to support the leading medical and health research conducted at The Queen Elizabeth Hospital and the Basil Hetzel Institute for Translational Health Research to improve the health of the South Australian community.

Project Pink Blue, registered as Health & Psychological Trust Centre is a cancer nonprofit engaged in raising cancer awareness, patient navigation, advocacy and free breast and cervical cancer screening for women living in poverty. The organization launched Nigeria's first patient navigation in 2015 and a toll- free telephone centre 08000CANCER in 2016 Project PINK BLUE won the SPARC Metastatic Breast Cancer challenge grant by Union for International Cancer Control and Pfizer Oncology in Lisbon, Portugal.

<span class="mw-page-title-main">The Urology Foundation</span> Charity organization

The Urology Foundation (TUF) is a charity that works across the UK and Ireland with the aim of improving the knowledge and skills of surgeons who operate on diseases of the male and female urinary-tract system and the male reproductive organs and funds research to improve outcomes of all urological conditions and urological cancers.

References

  1. Prostate Cancer Foundation of Australia Annual Report 2017-18
  2. Prostate Cancer Foundation of Australia Research Strategy 2019-22
  3. Prostate Cancer in Australia. Cancer series no. 79. Cat no. CAN 76. Australian Institute of Health and Welfare 2013.
  4. Lowe, A., Bennett, M., Badenoch, S. Research, Awareness, Support: Ten Years of Progress in Prostate Cancer. Prostate Cancer Foundation of Australia 2012. ISBN   978-0-646-58388-4
  5. pcfa.org.au/articleLive/pages/PCFA-Ambassador-Program.html
  6. Wong, W., Lowe, A., Dowsett, G., Duncan, D., O'Keeffe, D., Mitchell, M. Prostate Cancer Information Needs of Australian Gay and Bisexual Men. Prostate Cancer Foundation of Australia 2013. ISBN   978-0-9923335-8-4
  7. Development of Consumer Resources for Prostate Cancer. Zest Health Strategies 2012
  8. pcfa.org.au/articleLive/pages/Prostate-Cancer-Support-Groups